Severe Sepsis and Septic Shock

被引：58
|
作者：
Angus, Derek C. [1 ]
van der Poll, Tom [2 ,3 ]
机构：
[1] Univ Pittsburgh, CRISMA Clin Res Invest & Syst Modeling Acute Illn, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15261 USA
[2] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 369卷 / 09期
关键词：
ACTIVATED PROTEIN-C; INTENSIVE-CARE; ANTIMICROBIAL THERAPY; ORGAN DYSFUNCTION; UNITED-STATES; MORTALITY; EPIDEMIOLOGY; INFECTION; RESPONSES; EFFICACY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：840 / 851
页数：12
相关论文
共 50 条
  • [41] HYPOALBUMINEMIA AS A PROGNOSTIC FACTOR IN SEPSIS, SEVERE SEPSIS AND SEPTIC SHOCK
    Gupta, Leena
    James, Ben Siu
    CRITICAL CARE MEDICINE, 2012, 40 (12) : U198 - U198
  • [42] Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
    Alejandria, Marissa M.
    Lansang, Mary Ann D.
    Dans, Leonila F.
    Mantaring, Jacinto Blas, III
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (09):
  • [43] Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
    Dellinger, RP
    Carlet, JM
    Masur, H
    Gerlach, H
    Calandra, T
    Cohen, J
    Gea-Banacloche, J
    Keh, D
    Marshall, JC
    Parker, MM
    Ramsay, G
    Zimmerman, JL
    Vincent, JL
    Levy, MM
    CRITICAL CARE MEDICINE, 2004, 32 (03) : 858 - 873
  • [44] Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
    R. Phillip Dellinger
    Jean M. Carlet
    Henry Masur
    Herwig Gerlach
    Thierry Calandra
    Jonathan Cohen
    Juan Gea-Banacloche
    Didier Keh
    John C. Marshall
    Margaret M. Parker
    Graham Ramsay
    Janice L. Zimmerman
    Jean-Louis Vincent
    M. M. Levy
    Intensive Care Medicine, 2004, 30 : 536 - 555
  • [45] Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
    Dellinger, RP
    Carlet, JM
    Masur, H
    Gerlach, H
    Calandra, T
    Cohen, J
    Gea-Banacloche, J
    Keh, D
    Marshall, JC
    Parker, MM
    Ramsay, G
    Zimmerman, JL
    Vincent, JL
    Levy, MM
    INTENSIVE CARE MEDICINE, 2004, 30 (04) : 536 - 555
  • [46] Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes
    Martin, Greg S.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (06) : 701 - 706
  • [47] Implementation of surviving sepsis campaign guidelines for severe sepsis and septic shock
    Zambon, M
    Vincent, JL
    CRITICAL CARE MEDICINE, 2005, 33 (12) : A159 - A159
  • [48] On the diagnosis of adrenal insufficiency in severe sepsis and septic shock
    Spurzem, John R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (10) : 1095 - 1095
  • [49] Drotrecogin Alf (activated) in severe sepsis and septic shock
    Hussain, Aziza Muhammad
    ANAESTHESIA PAIN & INTENSIVE CARE, 2011, 15 (02) : 79 - 80
  • [50] Steroid treatment for patients with severe sepsis and septic shock
    Sprung, Charles L.
    Batzofin, Baruch
    Goodman, Serge
    Weiss, Yoram
    INTENSIVE CARE MEDICINE, 2011, 37 (09) : 1566 - 1566
12345